These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
197 related articles for article (PubMed ID: 23780687)
1. Predictors of cervical lymph node metastasis in salivary gland cancer. Ettl T; Gosau M; Brockhoff G; Schwarz-Furlan S; Agaimy A; Reichert TE; Rohrmeier C; Zenk J; Iro H Head Neck; 2014 Apr; 36(4):517-23. PubMed ID: 23780687 [TBL] [Abstract][Full Text] [Related]
2. Aberrations of MET are associated with copy number gain of EGFR and loss of PTEN and predict poor outcome in patients with salivary gland cancer. Ach T; Zeitler K; Schwarz-Furlan S; Baader K; Agaimy A; Rohrmeier C; Zenk J; Gosau M; Reichert TE; Brockhoff G; Ettl T Virchows Arch; 2013 Jan; 462(1):65-72. PubMed ID: 23242174 [TBL] [Abstract][Full Text] [Related]
3. Loss of PTEN is associated with elevated EGFR and HER2 expression and worse prognosis in salivary gland cancer. Ettl T; Baader K; Stiegler C; Müller M; Agaimy A; Zenk J; Kühnel T; Gosau M; Zeitler K; Schwarz S; Brockhoff G Br J Cancer; 2012 Feb; 106(4):719-26. PubMed ID: 22240798 [TBL] [Abstract][Full Text] [Related]
4. Overexpression of EGFR and absence of C-KIT expression correlate with poor prognosis in salivary gland carcinomas. Ettl T; Schwarz S; Kleinsasser N; Hartmann A; Reichert TE; Driemel O Histopathology; 2008 Nov; 53(5):567-77. PubMed ID: 18983466 [TBL] [Abstract][Full Text] [Related]
5. A prognostic index for predicting lymph node metastasis in minor salivary gland cancer. Lloyd S; Yu JB; Ross DA; Wilson LD; Decker RH Int J Radiat Oncol Biol Phys; 2010 Jan; 76(1):169-75. PubMed ID: 19386433 [TBL] [Abstract][Full Text] [Related]
6. EGFR, HER2, survivin, and loss of pSTAT3 characterize high-grade malignancy in salivary gland cancer with impact on prognosis. Ettl T; Stiegler C; Zeitler K; Agaimy A; Zenk J; Reichert TE; Gosau M; Kühnel T; Brockhoff G; Schwarz S Hum Pathol; 2012 Jun; 43(6):921-31. PubMed ID: 22154363 [TBL] [Abstract][Full Text] [Related]
7. Genomic aberrations of MDM2, MDM4, FGFR1 and FGFR3 are associated with poor outcome in patients with salivary gland cancer. Ach T; Schwarz-Furlan S; Ach S; Agaimy A; Gerken M; Rohrmeier C; Zenk J; Iro H; Brockhoff G; Ettl T J Oral Pathol Med; 2016 Aug; 45(7):500-9. PubMed ID: 26661925 [TBL] [Abstract][Full Text] [Related]
8. Head and neck salivary gland carcinomas--elective neck dissection, yes or no? Nobis CP; Rohleder NH; Wolff KD; Wagenpfeil S; Scherer EQ; Kesting MR J Oral Maxillofac Surg; 2014 Jan; 72(1):205-10. PubMed ID: 23891016 [TBL] [Abstract][Full Text] [Related]
9. Prognostic value of lymph node density in high-grade salivary gland cancers. Hong HR; Roh JL; Cho KJ; Choi SH; Nam SY; Kim SY J Surg Oncol; 2015 May; 111(6):784-9. PubMed ID: 25640975 [TBL] [Abstract][Full Text] [Related]
10. PIK3CA mutations and PTEN loss in salivary duct carcinomas. Griffith CC; Seethala RR; Luvison A; Miller M; Chiosea SI Am J Surg Pathol; 2013 Aug; 37(8):1201-7. PubMed ID: 23851329 [TBL] [Abstract][Full Text] [Related]
11. Increased gene copy number of HER2 and concordant protein overexpression found in a subset of eyelid sebaceous gland carcinoma indicate HER2 as a potential therapeutic target. Lee MJ; Kim N; Choung HK; Choe JY; Khwarg SI; Kim JE J Cancer Res Clin Oncol; 2016 Jan; 142(1):125-33. PubMed ID: 26141290 [TBL] [Abstract][Full Text] [Related]
12. Impact of postoperative radiotherapy and HER2/new overexpression in salivary duct carcinoma : A monocentric clinicopathologic analysis. Haderlein M; Scherl C; Semrau S; Lettmaier S; Hecht M; Erber R; Iro H; Fietkau R; Agaimy A Strahlenther Onkol; 2017 Nov; 193(11):961-970. PubMed ID: 28828496 [TBL] [Abstract][Full Text] [Related]
13. High incidence of lymph node metastasis in major salivary gland cancer. Stennert E; Kisner D; Jungehuelsing M; Guntinas-Lichius O; Schröder U; Eckel HE; Klussmann JP Arch Otolaryngol Head Neck Surg; 2003 Jul; 129(7):720-3. PubMed ID: 12874071 [TBL] [Abstract][Full Text] [Related]
14. A clinicopathological study and prognostic factor analysis of 177 salivary duct carcinoma patients from The Netherlands. Boon E; Bel M; van Boxtel W; van der Graaf WTA; van Es RJJ; Eerenstein SEJ; Baatenburg de Jong RJ; van den Brekel MWM; van der Velden LA; Witjes MJH; Hoeben A; Willems SM; Bloemena E; Smit LA; Oosting SF; ; Jonker MA; Flucke UE; van Herpen CML Int J Cancer; 2018 Aug; 143(4):758-766. PubMed ID: 29492965 [TBL] [Abstract][Full Text] [Related]
15. Patterns of nodal involvement for clinically N0 salivary gland carcinoma: refining the role of elective neck irradiation. Lau VH; Aouad R; Farwell DG; Donald PJ; Chen AM Head Neck; 2014 Oct; 36(10):1435-9. PubMed ID: 24038533 [TBL] [Abstract][Full Text] [Related]
16. EGFR and HER2-Akt-mTOR signaling pathways are activated in subgroups of salivary gland carcinomas. Suzuki S; Dobashi Y; Minato H; Tajiri R; Yoshizaki T; Ooi A Virchows Arch; 2012 Sep; 461(3):271-82. PubMed ID: 22828828 [TBL] [Abstract][Full Text] [Related]
17. [Clinical analysis of cervical lymph node metastasis of cN0 maxillary malignant tumor]. Sun Q; Zhang WB; Gao M; Yu S; Mao C; Guo CB; Yu GY; Peng X Beijing Da Xue Xue Bao Yi Xue Ban; 2017 Dec; 49(6):1050-1054. PubMed ID: 29263480 [TBL] [Abstract][Full Text] [Related]
18. Patterns of Lymph Node Metastasis in Parotid Cancer and Implications for Extent of Neck Dissection. Voora RS; Panuganti B; Califano J; Coffey C; Guo T Otolaryngol Head Neck Surg; 2023 May; 168(5):1067-1078. PubMed ID: 36939401 [TBL] [Abstract][Full Text] [Related]
20. Prognostic factors and outcome analysis of salivary duct carcinoma. Han MW; Roh JL; Choi SH; Nam SY; Lee HJ; Cho KJ; Lee SW; Kim SY Auris Nasus Larynx; 2015 Dec; 42(6):472-7. PubMed ID: 26028371 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]